2017 Leads Medical science 
European Pharmaceutical Review
MAY 23, 2024
In this Q&A, Dr Imran Khan, PhD, Vice President Medical Affairs, Hematology at Johnson & Johnson Innovative Medicine, highlights the current landscape of CAR T therapies such as CARVYKTI and touches on the future direction of the sector. Most recently, Imran has served as Medical Science Liaison (MSL) Head, Oncology U.S.
Medico Reach
JUNE 13, 2022
However, proper healthcare marketing has made prospects more aware of company insurance and other medical schemes. Although technology and medical sciences have come a long way, marketing healthcare services was difficult until 2017. Importance of Marketing Strategies in Healthcare Systems.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
NOVEMBER 3, 2022
This is due to aging populations around the world, which leads to an increased risk of such conditions, explains Craig Beavers, PhD, assistant professor at the University of Kentucky’s College of Pharmacy in Lexington. Also, substitution can lead to further shortages, he adds.
Medgadget
MARCH 2, 2023
This leads to substantial damage to healthy tissues and too often results in poor outcomes. This will hopefully lead to an FDA approval for its first indication, after which Alpha TAU plans on expanding to other types of cancer and geographic regions such as Europe and Japan. Results from initial clinical trials were quite impressive.
European Pharmaceutical Review
AUGUST 15, 2024
1 The cancer is a slow-growing but potentially life-threatening B-cell malignancy, in which increased activation of B-cell receptor signalling pathways leads to overgrowth of lymphocytes in bone marrow and other disease compartments. About the author Dr Mehrdad Mobasher, MPH, is the Chief Medical Officer for Hematology at BeiGene.
Expert insights. Personalized for you.
110 
Let's personalize your content